Karen Ingraham
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Pneumonia and Respiratory Infections, Bacterial Infections and Vaccines, Reproductive tract infections research, RNA and protein synthesis mechanisms
Most-Cited Works
- → A genomic analysis of two‐component signal transduction in Streptococcus pneumoniae(2000)318 cited
- → Identification, Evolution, and Essentiality of the Mevalonate Pathway for Isopentenyl Diphosphate Biosynthesis in Gram-Positive Cocci(2000)261 cited
- → Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin(2015)155 cited
- → Comparative Genomics of Klebsiella pneumoniae Strains with Different Antibiotic Resistance Profiles(2011)106 cited
- → Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections(2014)97 cited
- → Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae(2018)94 cited
- → Characterization of a Novel Fucose-Regulated Promoter (PfcsK) Suitable for Gene Essentiality and Antibacterial Mode-of-Action Studies inStreptococcus pneumoniae(2003)90 cited
- → A Global Approach to Identify Novel Broad-Spectrum Antibacterial Targets among Proteins of Unknown Function(2003)86 cited
- → Thiophene antibacterials that allosterically stabilize DNA-cleavage complexes with DNA gyrase(2017)84 cited
- → The bacA gene, which determines bacitracin susceptibility in Streptococcus pneumoniae and Staphylococcus aureus, is also required for virulence The GenBank accession number for the sequence reported in this paper is AF228662.(2000)82 cited